These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1770063)

  • 1. Recent progress in the treatment of diabetic nephropathy: importance of strict glycemic control on the regression of diabetic nephropathy.
    Kawamori R; Kamado K; Kamada T
    J Diabet Complications; 1991; 5(2-3):88-90. PubMed ID: 1770063
    [No Abstract]   [Full Text] [Related]  

  • 2. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
    Ohkubo Y; Kishikawa H; Araki E; Miyata T; Isami S; Motoyoshi S; Kojima Y; Furuyoshi N; Shichiri M
    Diabetes Res Clin Pract; 1995 May; 28(2):103-17. PubMed ID: 7587918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood glucose control.
    Uchino H; Kawamori R
    Contrib Nephrol; 2001; (134):106-12. PubMed ID: 11665280
    [No Abstract]   [Full Text] [Related]  

  • 4. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there any glycemic thresholds for the serious microvascular diabetic complications?
    Reichard P
    J Diabetes Complications; 1995; 9(1):25-30. PubMed ID: 7734740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of nephropathy in insulin-dependent diabetes mellitus is associated with poor glycemic control.
    Feldt-Rasmussen B
    Transplant Proc; 1994 Apr; 26(2):371-2. PubMed ID: 8171466
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
    Hanssen KF; Bangstad HJ; Brinchmann-Hansen O; Dahl-Jørgensen K
    Diabet Med; 1992 Oct; 9(8):697-705. PubMed ID: 1395460
    [No Abstract]   [Full Text] [Related]  

  • 9. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of persistent C-peptide secretion in type 1 (insulin-dependent) diabetes mellitus to glycaemic control and diabetic complications.
    Winocour PH; Jeacock J; Kalsi P; Gordon C; Anderson DC
    Diabetes Res Clin Pract; 1990 Apr; 9(1):23-35. PubMed ID: 2351037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic intermittent intravenous insulin therapy: a new frontier in diabetes therapy.
    Aoki TT; Grecu EO; Arcangeli MA; Benbarka MM; Prescott P; Ahn JH
    Diabetes Technol Ther; 2001; 3(1):111-23. PubMed ID: 11469701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 1 diabetes: long-term effects of intensive insulin therapy on diabetic retinopathy and nephropathy].
    Letonturier P
    Presse Med; 2000 Mar; 29(11):598. PubMed ID: 10776417
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin-dependent diabetes mellitus: pathophysiology.
    Gerich JE
    Mayo Clin Proc; 1986 Oct; 61(10):787-91. PubMed ID: 3528691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary C-peptide as an index of unstable glycemic control in insulin-dependent diabetes mellitus (IDDM).
    Cha T; Tahara Y; Ikegami H; Fukuda M; Yoneda H; Yamato E; Yamamoto Y; Noma Y; Shima K; Ogihara T
    Diabetes Res Clin Pract; 1991 Sep; 13(3):181-7. PubMed ID: 1959481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of blood pressure, lipid, and glycemic control in diabetic patients with nephropathy attending a hospital outpatient clinic and their relationship to renal function, mortality, and cardiovascular morbidity.
    Wahid ST; Baines LA; Savopoulos L; Connolly VM; Kelly WF; Bilous RW
    Diabetes Care; 2001 Apr; 24(4):789-90. PubMed ID: 11315853
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal functional reserve in IDDM patients.
    Sackmann H; Tran-Van T; Tack I; Hanaire-Broutin H; Tauber JP; Ader JL
    Diabetologia; 1998 Jan; 41(1):86-93. PubMed ID: 9498635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to prevent diabetic nephropathy or to delay its development].
    Grzeszczak W
    Pol Arch Med Wewn; 1995 Jul; 94(1):1-7. PubMed ID: 8524693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.